Clorox Q4 2024 Adj. EPS $1.82 Beats $1.56 Estimate, Sales $1.903B Miss $1.951B Estimate
Portfolio Pulse from Benzinga Newsdesk
Clorox (NYSE:CLX) reported Q4 2024 adjusted EPS of $1.82, beating the analyst estimate of $1.56. However, sales of $1.903 billion missed the $1.951 billion estimate and were down 5.75% from the same period last year.
August 01, 2024 | 8:11 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Clorox reported Q4 2024 adjusted EPS of $1.82, beating estimates by 16.67%, but sales of $1.903 billion missed estimates and were down 5.75% YoY.
The positive EPS surprise is offset by the sales miss and YoY decline, leading to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100